ProPhase Labs, Inc.
PRPH· OTC
Released Nov 12, 2021, before the open
10-Q filed Nov 12, 2021, 43 days after period end · 0001493152-21-028235
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $9.47M | $3.84M | $2.77M | $2.44M |
| Net Income | -$3.98M | -$408.00K | -$428.00K | -$1.06M |
| EPS Diluted |
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.04 |
| -$0.04 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.